Axitinib.svg


Summary

Description
English: Skeletal formula of axitinib (brand name Inlyta )—a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma .
Date
Source Own work
Author Vaccinationist

Licensing

I, the copyright holder of this work, hereby publish it under the following license:
w:en:Creative Commons
attribution share alike
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.

Captions

Skeletal formula of axitinib.

Items portrayed in this file

depicts

12 September 2023

image/svg+xml

7461991f28d75e0d7550d86cd694a6a8da2481b5

7,209 byte

298 pixel

512 pixel